Nephrology

65-77 of 77

• 

  RestartResume

  Is There Still Any Role for Plasma Exchange in AAV?

  RestartResume

  Is There Still Any Role for Plasma Exchange in AAV?

  KDIGO Conversations in Nephrology

  Is There Still Any Role for Plasma Exchange in AAV?

  Vladimir Tesar, MD; Michael Walsh, MD

  • 

    

    Vladimir Tesar, MD

  • 

    

    Michael Walsh, MD

• 

  RestartResume

  Challenges in the Early Diagnosis of AAV 

  RestartResume

  Challenges in the Early Diagnosis of AAV 

  KDIGO Conversations in Nephrology

  Challenges in the Early Diagnosis of AAV 

  Vladimir Tesar, MD; Duvuru Geetha, MD

  • 

    

    Vladimir Tesar, MD

  • 

    

    Duvuru Geetha, MD

• 

  RestartResume

  The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT Patients

  RestartResume

  The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT Patients

  KDIGO Conversations in Nephrology

  The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT Patients

  Marlies Ostermann, MD; Rinaldo Bellomo, MBBS, MD, FRACP

  • 

    

    Marlies Ostermann, MD

  • 

    

    Rinaldo Bellomo, MBBS, MD, FRACP

• 

  RestartResume

  Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI 

  RestartResume

  Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI 

  KDIGO Conversations in Nephrology

  Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI 

  Marlies Ostermann, MD; Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP

  • 

    

    Marlies Ostermann, MD

  • 

    

    Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP

• 

  RestartResume

  Best Practices in Fluid Management During CKRT

  RestartResume

  Best Practices in Fluid Management During CKRT

  KDIGO Conversations in Nephrology

  Best Practices in Fluid Management During CKRT

  Marlies Ostermann, MD; Javier Neyra, MD, MSCS

  • 

    

    Marlies Ostermann, MD

  • 

    

    Javier Neyra, MD, MSCS

• 

  RestartResume

  KDIGO Conversations in Nephrology: Deciding When and Who Should Start Acute Dialysis - From Evidence to Bedside Practice

  RestartResume

  KDIGO Conversations in Nephrology: Deciding When and Who Should Start Acute Dialysis - From Evidence to Bedside Practice

  Nephrology

  KDIGO Conversations in Nephrology: Deciding When and Who Should Start Acute Dialysis - From Evidence to Bedside Practice

  Ravindra L. Mehta, MD; Marlies Ostermann, MD

  • 

    

    Ravindra L. Mehta, MD

  • 

    

    Marlies Ostermann, MD

• 

  RestartResume

  KDIGO Conversations in Nephrology: How to Develop an Acute Dialysis Care Quality Program - Quality Metrics and Continuous Improvement

  RestartResume

  KDIGO Conversations in Nephrology: How to Develop an Acute Dialysis Care Quality Program - Quality Metrics and Continuous Improvement

  Nephrology

  KDIGO Conversations in Nephrology: How to Develop an Acute Dialysis Care Quality Program - Quality Metrics and Continuous Improvement

  Ravindra L. Mehta, MD; Theresa Mottes, APRN-NP, CPNP-AC, CDN

  • 

    

    Ravindra L. Mehta, MD

  • 

    

    Theresa Mottes, APRN-NP, CPNP-AC, CDN

• 

  RestartResume

  KDIGO Conversations in Nephrology: Maximizing Filter Life During CRRT – Best Practices on Anticoagulation and Citrate Use

  RestartResume

  KDIGO Conversations in Nephrology: Maximizing Filter Life During CRRT – Best Practices on Anticoagulation and Citrate Use

  Nephrology

  KDIGO Conversations in Nephrology: Maximizing Filter Life During CRRT – Best Practices on Anticoagulation and Citrate Use

  Ravindra L. Mehta, MD; Ashita Tolwani, MD

  • 

    

    Ravindra L. Mehta, MD

  • 

    

    Ashita Tolwani, MD

• 

  RestartResume

  AFFIRM-AHF: Key Takeaways

  RestartResume

  AFFIRM-AHF: Key Takeaways

  Global Heart Failure Academy

  AFFIRM-AHF: Key Takeaways

  Ewa A. Jankowska, MD, PhD, FESC

  • 

    

    Ewa A. Jankowska, MD, PhD, FESC

• 

  RestartResume

  Late-breaking First Response on AFFIRM-AHF

  RestartResume

  Late-breaking First Response on AFFIRM-AHF

  Global Heart Failure Academy

  Late-breaking First Response on AFFIRM-AHF

  Stefan D. Anker, MD, PhD; Javed Butler, MD

  • 

    

    Stefan D. Anker, MD, PhD

  • 

    

    Javed Butler, MD

  • 

    

    Ewa A. Jankowska, MD, PhD, FESC

  • 

    

    Josep Comin-Colet, MD, PhD

• 

  RestartResume

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

  RestartResume

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

  Global Heart Failure Academy

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

  Mikhail Kosiborod, MD

  • 

    

    Mikhail Kosiborod, MD

• 

  RestartResume

  Balancing RAASi Therapy and Potassium: Understanding How it Works

  RestartResume

  Balancing RAASi Therapy and Potassium: Understanding How it Works

  Global Heart Failure Academy

  Balancing RAASi Therapy and Potassium: Understanding How it Works

• 

  RestartResume

  Mechanisms in Heart Failure: Why Iron Deficiency Matters

  RestartResume

  Mechanisms in Heart Failure: Why Iron Deficiency Matters

  Global Heart Failure Academy

  Mechanisms in Heart Failure: Why Iron Deficiency Matters

• Previous
• 1
• 2
• 3
• 4
• 5
• Next